Treatment

EA-230 90mg/kg/hour clinical trials

1 indexed studies · 1 currently recruiting

Not yet recruitingPHASE3
A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
This study is testing a new medicine, EA-230, to see if it helps people recover faster after heart bypass surgery. It aims to reduce hospital stays and serious problems. We're looking for adults having this common heart operation.
For: Coronary Artery Disease (CAD) · Coronary Artery Bypass Graft Surgery(CABG)
United States · Belgium · Netherlands